Lonza Biologics Tuas Overview
- Founded
-
2007
- Status
-
Private
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$6.48M
Lonza Biologics Tuas General Information
Description
Provider of a medical research and development services intended to offer large-scale cell culture manufacturing facilities. The company's medical research and development services offers a site for the production of monoclonal antibodies and recombinant proteins, enabling its clients to receive treatment related to large-scale cell culture.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 35 Tuas South Avenue 6
- Singapore, 637377
- Singapore
+65 6521 0000
Lonza Biologics Tuas Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 27-Aug-2008 | $6.48M | 000.00 | Completed | Generating Revenue | |
| 2. Early Stage VC | Completed | Generating Revenue | ||||
| 1. Joint Venture | 01-Jan-2007 | Completed | Generating Revenue |
Lonza Biologics Tuas Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Stephan Kutzer Ph.D | Self | Chairman | 000 0000 |